Physician
Metro Asthma and Allergy Centers
Metro Asthma and Allergy Centers was paid $2.77M by Medicaid between Jan 2019 and Dec 2024, across 18 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 44% of everything it billed.
33Billing provider infoMETRO ASTHMA AND ALLERGY CENTERS
MITCHELLVILLE, MD 20721
MITCHELLVILLE, MD 20721
33aNPI1730252438assigned 11/17/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$2.77M
24GClaims52,690
24DCodes billed18
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Maryland
Rank by total paid#2 of 18
Median peer was paid$171K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 6,301 | $321K | |
| 2020 | 10,178 | $491K | |
| 2021 | 9,190 | $453K | |
| 2022 | 8,088 | $425K | |
| 2023 | 9,825 | $604K | |
| 2024incomplete | 9,108 | $479K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 44% | 4,452 | 3,072 | $1.23M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 17% | 2,943 | 2,045 | $480K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 5,004 | 3,907 | $433K |
| 95117 | 7.4% | 21,598 | 8,484 | $206K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 776 | 708 | $103K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.6% | 4,825 | 2,007 | $100K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.3% | 960 | 830 | $63K |
| 95115 | 1.6% | 5,659 | 2,607 | $46K | |
| 94010 | 1.2% | 1,498 | 1,256 | $33K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,854 | 1,514 | $24K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 177 | 141 | $18K |
| 95125 | <1% | 934 | 359 | $17K |
6 more codes
| 94060 | <1% | 369 | $11K | |
| 99205 | Prolong outpt/office vis | <1% | 38 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,399 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $1K |
| 90756 | <1% | 69 | $1K | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 123 | $4.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAKIA, ASEK (OWNER)